AIkido Pharma Inc.
AIkido Pharma Inc., a biotechnology company, focuses on developing small-molecule anti-cancer therapeutics. Its pipeline of therapeutics includes therapies for pancreatic cancer, acute myeloid leukemia, and acute lymphoblastic leukemia. It is developing DHA-dFdC, a pancreatic drug candidate; and KPC34, a small molecule treatment for acute myeloid leukemia and acute lymphoblastic leukemia. The Company is also developing an antiviral platform that inhibits replication of multiple viruses, including influenza virus, SARS-CoV, MERS-CoV, Ebolavirus, and Marburg virus. It has a license agreement with the University of Texas; and Wake Forest University Health Sciences. The company was formerly known as Spherix Incorporated and changed its name to AIkido Pharma Inc. in March 2021. AIkido Pharma Inc. was founded in 1967 and is based in New York, New York. Show More...
-
Website http://www.aikidopharma.com
-
Sector Healthcare
-
Industry Biotechnology
-
Last Quote 3.80 USD
-
Last Updated 22-02-2023
-
External Links Yahoo Finance Morningstar Ratios
-
Interest Coverage
The interest coverage ratio is a debt ratio and profitability ratio used to determine how easily a company can pay interest on its outstanding debt.
Reference: Investopedia -
2010-12 2011-12 2012-12 2013-12 2014-12 2015-12 2016-12 2017-12 2018-12 2019-12 TTM Earnings Per Share USD -6912.15 -415.05 -1136.95 -1101.42 -124.99 -106.17 27.67 -2.55 0.91 -1.67 -2.01 Dividends USD Payout Ratio % * Shares Mil 1.0 1.0 2.0 3.0 4.0 Book Value Per Share * USD 3358.71 2517.31 84.8 164.51 165.74 11.76 7.75 3.46 3.28 1.78 0.6 Free Cash Flow Per Share * USD -7775.67 -3517.91 -1127.25 -687.09 -45.43 -22.94 -0.010 -2.77 -1.73 -1.24 Return on Assets % -90.1 -54.63 -74.09 -48.16 -46.61 -113.03 200.26 -32.65 15.54 -34.1 -67.81 Financial Leverage (Average) 1.58 1.2 5.56 1.45 1.14 1.56 2.12 2.19 1.1 1.07 1.03 Return on Equity % -132.11 -75.62 -138.51 -73.09 -59.93 -135.73 355.47 -70.16 21.32 -36.97 -71.2 Return on Invested Capital % -132.21 -75.67 -138.51 -73.09 -59.26 -133.61 340.14 -68.48 21.32 -36.97 -71.2 Interest Coverage Current Ratio 3.51 6.19 6.42 2.18 3.59 0.87 2.36 1.69 2.52 1.51 26.92 Quick Ratio 3.19 5.82 6.14 2.08 3.5 0.79 2.31 1.63 2.36 1.26 26.66 Debt/Equity 0.010 0.03 0.010